Epigenomics AG (XTER:ECX)
€ 0.7 -0.088 (-11.17%) Market Cap: 490,000.00 Enterprise Value: -2.74 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 45/100

Q3 2022 Epigenomics AG Earnings Call Transcript

Nov 09, 2022 / 03:00PM GMT
Release Date Price: €6.6 (+4.76%)
Operator

Ladies and gentlemen, welcome to the Epigenomics AG conference call regarding the results of the first 9 months of 2022. (Operator Instructions)

Let me now turn the floor over to your host, Frederic Hilke. Please go ahead.

Frederic Hilke
Epigenomics AG - IR Officer

Thank you very much, Alexander. Hello, and welcome to Epigenomics investor conference call. My name is Frederic Hilke. I'm the Investor Relations Manager for Epigenomics. With me on the phone is the CEO of Epigenomics AG, Greg Hamilton.

On today's call, we will be discussing the results for the first 9 months 2022. This call is being webcast for anyone who would like to follow the presentation. The link can be found on the Epigenomics website in the IR section.

Before I hand over the presentation to Greg, let me point out some of the usual legal information. The following presentation will contain expressly or implicitly certain forward-looking statements concerning Epigenomics AG and its business. Such statements involve certain known and unknown risks, uncertainties

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot